ALVO Total Utang marang Modal Alvotech Biopharmaceuticals

Lambang korporat lan logo Alvotech (ALVO)

The market price confirmed by this chart demonstrates a total debt-to-equity ratio of 0.00 for Alvotech (ALVO). This price action is based on the launch of high-cost drug analogs, rendering revenue growth independent of economic cycles. The business relies on complex internal technical processes and long-term B2B deals, creating a protected supply environment. Alvotech (ALVO) is expanding market access through strategic alliances with global pharma behemoths to optimize logistics.

ALVO: Total Utang marang Modal Alvotech SA 28.04.2023 - 28.10.2026

Rincian analitis lan laporan data perusahaan Alvotech Biopharmaceuticals (ALVO)

- rega lan prakiraan konsensus rega:
Bagan rega Alvotech SA|ALVO - Bagan tingkat prakiraan
- data kapitalisasi pasar:
Kapitalisasi pasar Alvotech|ALVO - Nilai Dipunlarasaken Utang lan Kas
- data kapitalisasi buku:
Nilai Buku saben Saham Alvotech|ALVO - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku alvotech.com|ALVO - Nilai Agregat Aset
- data utang lan likuiditas:
Utang marang Ekuitas Alvotech|ALVO - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Alvotech|ALVO - Gunggung utang perusahaan|Utang marang nilai buku Alvotech
Analisis komprehensif perusahaan:ALVO - Alvotech SA
Produk merek Alvotech Biopharmaceuticals

This ratio measures financial leverage by comparing total credit obligations to net owner assets, allowing for an assessment of risks associated with dependence on borrowed capital. By analyzing the debt-to-equity chart, an investor can determine the resilience of Alvotech (ALVO) to borrowing costs, which is critical when scaling capacities in Iceland and facing fierce price competition in the biosimilars segment.

Pesaing wigati

Utang marang Ekuitas Haleon HLN|Utang Agregat marang Ekuitas Kenvue Inc|Verona Pharma Corp (VRNA) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Jyong Bio (MENS)|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|amneal.com - Total Utang marang Modal|Utang marang Ekuitas Perrigo (PRGO)|LQDA: Rasio Kabeh Utang marang Dana Pribadi|GLPG (Galapagos Genomics) - Utang marang Ekuitas|ANI Pharmaceuticals Corp (ANIP) - Rasio Total Utang marang Ekuitas|MNKD (MannKind Corporation) - Total Utang marang Modal|Total Utang marang Modal amphastar.com (AMPH)|Pacira BioSciences, Inc. (PCRX) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SPRY (ARS Pharmaceuticals Inc)|TBPH: Utang marang Ekuitas|AQST - Utang marang Modal|Rasio Total Utang marang Ekuitas scPharma SCPH|TECX - Utang Agregat marang Modal|Total Utang marang Modal Tonix Pharmaceuticals Holding Corp. TNXP|China SXT Pharmaceuticals, Inc. (SXTC) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal EPRX (Eupraxia Pharmaceuticals, Inc.)|Utang marang Modal BHST|eXoZymes Inc (EXOZ) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi oramed.com (ORMP)|Total Utang marang Modal ENTX (Entera Bio)|MindWalk Holdings, Inc. - Total Utang marang Modal|ABVC - Utang marang Ekuitas|Cumberland Corp (CPIX) - Utang marang Ekuitas|Quantum BioPharma Ltd (QNTM) - Rasio Total Utang marang Ekuitas|FGEN (fibrogen.com) - Utang marang Ekuitas|Utang marang Ekuitas TELO (Telomir Pharmaceuticals, Inc.)|Utang marang Modal Rani Therapeutics Inc (RANI)|Rasio Total Utang marang Ekuitas Synergy CHC Corp|Utang Agregat marang Modal rallybio.com (RLYB)|LEXX: Total Utang marang Modal|Utang marang Modal pulmatrix.com PULM|PTHL: Total Utang marang Modal|APM - Rasio Total Utang marang Ekuitas|Total Utang marang Modal Lyra Therapeutics, Inc LYRA|Impact BioMedical, Inc. (IBO) - Rasio Kabeh Utang marang Dana Pribadi|TNFA (TNF Pharmaceuticals Inc.) - Total Utang marang Modal|Total Utang marang Modal YCBD|Utang marang Ekuitas PainReform (PRFX)|Utang marang Ekuitas altamiratherapeutics.com CYTO|Rasio Total Utang marang Ekuitas Lipella LIPO|OptiNose Corp - Utang marang Ekuitas|PIRS (Pieris Pharmaceuticals) - Utang marang Ekuitas|PROC: Utang marang Modal|Utang marang Ekuitas Petros Pharmaceuticals, Inc. (PTPI)|Qilian International Holding Group (QLI) - Utang Agregat marang Ekuitas|SLRN - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi TFF Pharmaceuticals, Inc